The present study included 296 ER-negative and 555 ER-positive invasive breast cancer cases, allowing for validation of the previously published ER-specific PRS and examination of whether adding an ER-specific PRS improves discriminatory accuracy. Here, ESR1 is linked to invasive breast carcinoma.